Search Results

Refine by Audience:

Your search for pilot research returned 595 results.

Displaying 51 to 60 of 595 records
Sort by: Page: << Prev 3… 4… 5… 6… 7… 8… 9… Next >>

Nuclear Medicine and Radiation Safety – Jan 30, 2024
Radiopharmaceuticals can save lives and improve a patient's quality of life. This page offers information on the risks vs. benefits of radiation exposure.
Cassen Award Recipients – Jan 22, 2024
list of historical
New PET/CT Technique Accurately Diagnoses Adrenal Gland Disorder, Informs Personalized Treatment Plans – Jan 18, 2024
A novel imaging approach, Ga-68 pentixafor PET/CT, has been shown to accurately identify sub-types of primary aldosteronism, outperforming traditional methods for diagnosis, according to research published in JNM.
Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer, Offers Potential for Targeted Therapy – Jan 11, 2024
A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer in preclinical and clinical studies, according to research published in JNM.
Interview with Dr. Marina Sharifi and LBCA – Jan 10, 2024
SNMMI member interviews to inform patients.
JNM Publishes Procedure Standard/Practice Guideline for FES PET Imaging of Breast Cancer – Jan 5, 2024
SNMMI and EANM have issued a new procedure standard/practice guideline for estrogen receptor imaging of breast cancer patients using FES PET.
Neurology-Specific Information – Dec 20, 2023
For Referring Physicians
Ga-68 FAPI PET Improves Detection and Staging of Pancreatic Cancer – Dec 20, 2023
PET imaging with Ga-68 FAPI can more effectively detect and stage pancreatic cancer as compared with 18F-FDG imaging or contrast-enhanced CT, according to new research published in JNM. In addition, Ga-68 FAPI imaging paves the way for future targeted radiopharmaceutical therapies.
New PET Tracer Noninvasively Identifies Cancer Gene Mutation, Allows for More Precise Diagnosis and Therapy – Dec 19, 2023
A novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for tumor-targeted therapy, according to research published in The Journal of Nuclear Medicine.
HPRA December 2023 Newsletter – Dec 14, 2023
SNMMI Health Policy and Regulatory Affairs Department released its December 2023 Newsletter. Highlights include updates on CMS HOPPS Rules, The FIND Act, and other legislative initiatives.

Displaying 51 to 60 of 595 records
Page: << Prev 3… 4… 5… 6… 7… 8… 9… Next >>